Health Briefs: Alzheimer's And Cancer

You don't hear a lot of good news about Alzheimer's disease. Cases continue to mount--5 million Americans and counting--and there are still only a handful of drugs available to treat it, all of which work only in the early stages of the disease. So it was with some excitement that doctors read the report in the New England Journal of Medicine last week about the first treatment that can slow the progression of the disease in advanced cases.

The drug is called memantine. It has been used for more than a decade in Europe for various neurological conditions, including Parkinson's....

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!